Michael Brodowski

Background

About Michael Brodowski

Michael H. Brodowski is a partner in Goodwin’s nationally recognized Life Sciences group and a member of its Intellectual Property practice. Dr. Brodowski advises companies, investors, and academic and research institutions on patent and other IP related matters. He has extensive experience in strategic development and implementation of complex patent portfolio and market exclusivity strategies in the US and abroad for Life Sciences companies. Dr. Brodowski primarily advises clients in connection with the protection and exploitation of patent and other IP rights to support their business objectives. He has significant experience and knowledge in developing and managing domestic and foreign patent portfolios including post-grant proceedings such as patent reexamination, reissue and foreign opposition proceedings. Dr. Brodowski has obtained protection for various FDA approved products and advises on patent life cycle management including patent term extension (PTE) and other exclusivities. He analyzes patent landscapes to evaluate patentability and freedom-to-operate. Dr. Brodowski counsels on the Bayh-Dole Act and its impact on inventions made with federal government funding, actions under the Act, and related matters. He conducts IP due diligence for public and private business transactions such as investments in public and privately-held companies, public offerings, licensing transactions, and mergers and acquisitions. He prepares patent opinions regarding infringement and invalidity; and advises on patent license and other technology-related agreements. Dr. Brodowski counsels clients in a diverse range of technologies in the fields of chemistry including small molecules and pharmaceuticals, plastics and polymers, drug delivery technologies, specialty chemicals and chemical manufacturing; materials science and nanotechnology including composite materials; energy including petroleum processing, fuel cells, solar cells and biofuels; biotechnology; environmental remediation; and health care including diagnostic assays, medical devices and personal care products Before entering the legal profession, Michael worked in the Product Development Group of the Toiletries Technology Laboratory of The Gillette Company. He is the first named inventor on U.S. and foreign patents.